Skip to main content
Charles David Allis, a molecular biologist who shaped the field of chromatin biology, died on January 8 at the age of 71.

It's not just the number of mutations that matters. It's the failure to fix them too.

A novel method reduces the time required to identify novel antibiotic-producing DNA from weeks to days.

While most germinal centers shut down after a few weeks, some stay in business for more than six months. A new study helps explain why.

Breakthroughs in genetics, biochemistry, neuroscience, infectious disease, and drug development were a few of the year's highlights.

The library is offering new tools and training to support researchers operating under an updated NIH policy.

The findings shed a rare light on mitoribosomes, the unique ribosomes found within the cell's mitochondria.

People who receive monoclonal antibodies before vaccines may benefit from increased coverage, due to antibody feedback inhibition.

Patients with Fanconi anemia have an elevated risk for squamous cell carcinoma, a highly aggressive head-and-neck cancer. New findings pinpoint the mechanisms linking the two conditions, and also shed new light on how smoking or drinking may elevate anyone’s cancer risk.

The findings suggest that many of the mutations in cancer may simply be setting in stone a path already forged by the tumor stem cell’s aberrant dialogue with its surroundings.